I got out in stages, first to use profits to complete retirement home and then to avoid losses. I bought in the low 2s and sold in the 6s, 5s and held a core amount until $2.90s when it was apparent this stock was taking a beating. GALE was the last stock I sold, not the first. I blame management for not using better marketing sense at best, and at worst for selling large amounts with horrible timing. That said, they are not marketing specialists, they are scientists. The problem every small investor is facing is the question of whether there is more to the story. There may well be, but I don't personally believe it has any impact on the science or the ultimate success of their drug trials. IMO, it would be a big mistake to sell now, especially below $2.00. I'll continue to watch this from a mile up in the San Bernardino mountains but am out of the market at the moment with my money in real estate instead of the market. For every person who has a family member, friend or knows somebody who could benefit from Gale's success, along with the many true Gale longs, I wish you all the best of luck.
After years of making money on SPPI buying low and selling high, I held a core amount and it was a big mistake. I've been out for a long time and looked in today to see how things were going. SSDD. Raj continues to get rich and the stock price is nearing a 52 week low. Seriously?
Of course a dolt like you knows far more than those who raised the price target to $11. Why do you waste your time? Do you actually believe anybody gives a S about you or your posts?
Sentiment: Strong Buy
I am always amazed how somebody like you gets on a computer and manages to use it. You are probably on the CVX and OXY boards posting that cold fusion has been perfected. One solution: IGNORE USER
The fact is, you are a sore loser who should not be in the market. You don't know how to lock in some profit during runs. You rode it down like a scared monkey clutching a banana falling from a tree. Now, you hang around like a penniless hobo. LOL
What happened to your "Dead Cat Bounce" claim? Oh, that's right. You just keep up your unreliable #$%$ as if you were not wrong. How about, "Oh Boy Did We Ever Get This One Wrong"?
6. 55 or 6.25 matters little if you are holding. If you are accumulating, it might be a positive. If you're scrounging for pennies and trying to scare small investors, karma is a #$%$.
The Street is the most overtly manipulative bag of nonsense out there. This dead cat bounce "headline" gives them wide notice on the web. It matters little if it turns out to be accurate on an individual stock or historically for everything they publish. They are no better than horoscopes that predict wealth or loss of it. Once in awhile, odds say the will be right and then they can talk about that.
I don't dispute what you have said. If I did, I still would not own GALE. However, in spite of all of the Cramer and Feurstein and short trading nonsense, the questions I posed remain to be answered.
I certainly respect your insight and am no fan of frivolous litigation. If can agree that the following happened, then an investigation of the facts (a lawsuit only depending upon the outcome of the investigation) is in order.
1. GALE management hired a firm to promote GALE in forums such as Seeking Alpha;
2. GALE management failed to disclose number 1 to shareholders; and,
3. GALE management was unloading large amounts of stock as the share price rose.
The questions to be answered:
1. Was the retention of the firm a material event that should have been fully disclosed to shareholders?
2. Was the manner in which the firm marketed improper and was GALE management knowledgeable?
3. Did/Do GALE management have material information regarding GALE (Abstral sales, Neuvax trials) that may negatively impact the share price that they failed to disclose while themselves selling?
If the answers to these three questions are no, then no problem and any lawsuit filed should be a waste of the paper. If the answers to one or more (and particularly all three) are yes, we have a significant problem.
Very unlikely. Let's face the facts here. Anyone who has been around for a year or more knows that I have been pro-GALE. I still own it. That said, law firms come out of the woodwork to "investigate" biotechs that undergo trial or NDA failures and undergo big shareprice drops to see if management was pumping while selling, failing to disclose material facts. Here, there is apparently evidence that GALE management retained an organization to promote GALE and as the shareprice rose while management was unloading stock. To me, the question is why. Was management selling unrelated to anything they know about Abystral sales, Neuvax trials, or anything else happening that may negatively impact the share price? Was the retention marketing plan a material event and should it have been disclosed? If not, no big deal IMO. If so, people should be stripped of their illicit gains and face prosecution.
This WAS a great thread - for identifying a whole series of Ignore User candidates.